Healthcare Analysts Karnauskas and Devarakonda, along with cardiologist Dr. Liviu Klein, discuss the competitive landscape for Hypertrophic Cardiomyopathy (Bristol-Myers Squibb/Cytokinetics on an Analyst/Industry conference call to be held on January 23 at 11 am. Webcast Link
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BMY:
- Schrodinger, Bristol-Myers amend development pact to include neurology
- 2seventy Bio jumps 11% on release of positive results in KarMMa-3 study
- Aurinia worth ‘keeping closer eye on’ after settlement, Dealreporter says
- NccRCC ‘material expansion opportunity’ for Exelixis, says William Blair
- Exelixis announces initiation of STELLAR-304 Phase 3 trial of zanzalintinib